At time of sacrifice, significant higher CD4+ T cell numbers were detected within the tumor-infiltrating lymphocytes (TILs) and tumor-draining lymph nodes (TDLN) of B16SLC35A1 tumors (Figure 1G). This evidence concerns the gene CD4 and neoplasm.